What was the market valuation of the China herbal medicine market in 2024?

The market valuation was $8.61 Billion in 2024. Read More

What is the projected market valuation for the China herbal medicine market by 2035?

The projected valuation for 2035 is $35.68 Billion. Read More

What is the expected CAGR for the China herbal medicine market during the forecast period 2025 - 2035?

The expected CAGR is 13.8% during the forecast period 2025 - 2035. Read More

Which distribution channel generated the highest revenue in the China herbal medicine market in 2024?

The Hospital & Retail Pharmacies segment generated $5.16 Billion in 2024. Read More

What are the leading categories in the China herbal medicine market based on 2024 data?

The leading categories include Herbal Pharmaceuticals and Herbal Functional Foods, each valued at $2.58 Billion in 2024. Read More

Which type of medicinal plants is projected to perform well in the China herbal medicine market?

Medicinal plants like Camellia Sinensis and Curcuma Longa are projected to perform well, with each valued at $1.29 Billion and $0.86 Billion respectively in 2024. Read More

What was the revenue generated by herbal dietary supplements in 2024?

Herbal dietary supplements generated $1.72 Billion in 2024. Read More

How does the revenue from e-commerce compare to traditional distribution channels in 2024?

E-commerce generated $3.45 Billion, which is lower than the $5.16 Billion from Hospital & Retail Pharmacies in 2024. Read More

What is the projected growth for herbal beauty products in the China herbal medicine market?

Herbal beauty products are projected to grow from $1.73 Billion in 2024 to a higher valuation by 2035. Read More

China Herbal Medicine Market

Q: Who are the key players in the China herbal medicine market?

Key players include Herbalife, Nature's Way, Gaia Herbs, Schwabe Pharmaceuticals, Traditional Medicinals, Himalaya Wellness, Dabur, and Zandu Pharmaceutical Works. Read More

ID: MRFR/MED/42324-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

China Herbal Medicine Market Research Report By Herbal Medicine Form Outlook (Extracts, Powders, Capsules Tablets, Syrups), By Herbal Medicine Distribution Channel Outlook (Hospital Retail Pharmacies, E-Commerce), By Herbal Medicine Category Outlook (Herbal Pharmaceuticals, Herbal Functional Foods, Herbal Beauty Products, Herbal Dietary Supplements), By Herbal Medicine Type of Medicinal Plants (Marrubium Vulgare, Vaccinium Macrocarpon, Echinacea, Curcuma Longa, Camellia Sinensis, Actaea Racemose, Aloe Vera, Zingiber Officinale, Cocos Nucifera, Cinnamomum Spp, Allium Sativum) and By Herbal Medicine Source Outlook (Leaves, Root Barks, Whole Plants, Fruits) - Growth & Industry Forecast 2025 To 2035

China Herbal Medicine Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)13.8%

2024 Market Size$ 8.61 Billion

2025 Market Size$ 9.8 Billion

2035 Market Size$ 35.68 Billion

Key Players

Herbalife

Nature's Way

Gaia Herbs

Schwabe Pharmaceuticals

Traditional Medicinals

Himalaya Wellness

Trends

Rising Demand for Natural Remedies
Technological Integration in Product Access
Evolving Regulatory Frameworks

Opportunities

E-commerce Expansion
Growing Consumer Awareness
Increasing Health Consciousness

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Security, Access Control and Robotics, BY Form (USD Billion)
  1. 4.1.1 Extracts
  2. 4.1.2 Powders
  3. 4.1.3 Capsules & Tablets
  4. 4.1.4 Syrups
2. 4.2 Security, Access Control and Robotics, BY Distribution Channel (USD Billion)
  1. 4.2.1 Hospital & Retail Pharmacies
  2. 4.2.2 E-Commerce
3. 4.3 Security, Access Control and Robotics, BY Category (USD Billion)
  1. 4.3.1 Herbal Pharmaceuticals
  2. 4.3.2 Herbal Functional Foods
  3. 4.3.3 Herbal Beauty Products
  4. 4.3.4 Herbal Dietary Supplements
4. 4.4 Security, Access Control and Robotics, BY Type of Medicinal Plants (USD Billion)
  1. 4.4.1 Marrubium Vulgare
  2. 4.4.2 Vaccinium Macrocarpon
  3. 4.4.3 Echinacea
  4. 4.4.4 Curcuma Longa
  5. 4.4.5 Camellia Sinensis
  6. 4.4.6 Actaea Racemose
  7. 4.4.7 Aloe Vera
  8. 4.4.8 Zingiber Officinale
  9. 4.4.9 Cocos Nucifera
  10. 4.4.10 Cinnamomum Spp
  11. 4.4.11 Allium Sativum
5. 4.5 Security, Access Control and Robotics, BY Source (USD Billion)
  1. 4.5.1 Leaves
  2. 4.5.2 Root & Barks
  3. 4.5.3 Whole Plants
  4. 4.5.4 Fruits
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Security, Access Control and Robotics
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Security, Access Control and Robotics
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Herbalife (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Nature's Way (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Gaia Herbs (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Schwabe Pharmaceuticals (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Traditional Medicinals (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Himalaya Wellness (IN)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Dabur (IN)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Zandu Pharmaceutical Works (IN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY FORM
3. 6.3 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
4. 6.4 CHINA MARKET ANALYSIS BY CATEGORY
5. 6.5 CHINA MARKET ANALYSIS BY TYPE OF MEDICINAL PLANTS
6. 6.6 CHINA MARKET ANALYSIS BY SOURCE
7. 6.7 KEY BUYING CRITERIA OF SECURITY, ACCESS CONTROL AND ROBOTICS
8. 6.8 RESEARCH PROCESS OF MRFR
9. 6.9 DRO ANALYSIS OF SECURITY, ACCESS CONTROL AND ROBOTICS
10. 6.10 DRIVERS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
11. 6.11 RESTRAINTS IMPACT ANALYSIS: SECURITY, ACCESS CONTROL AND ROBOTICS
12. 6.12 SUPPLY / VALUE CHAIN: SECURITY, ACCESS CONTROL AND ROBOTICS
13. 6.13 SECURITY, ACCESS CONTROL AND ROBOTICS, BY FORM, 2024 (% SHARE)
14. 6.14 SECURITY, ACCESS CONTROL AND ROBOTICS, BY FORM, 2024 TO 2035 (USD Billion)
15. 6.15 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
16. 6.16 SECURITY, ACCESS CONTROL AND ROBOTICS, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
17. 6.17 SECURITY, ACCESS CONTROL AND ROBOTICS, BY CATEGORY, 2024 (% SHARE)
18. 6.18 SECURITY, ACCESS CONTROL AND ROBOTICS, BY CATEGORY, 2024 TO 2035 (USD Billion)
19. 6.19 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE OF MEDICINAL PLANTS, 2024 (% SHARE)
20. 6.20 SECURITY, ACCESS CONTROL AND ROBOTICS, BY TYPE OF MEDICINAL PLANTS, 2024 TO 2035 (USD Billion)
21. 6.21 SECURITY, ACCESS CONTROL AND ROBOTICS, BY SOURCE, 2024 (% SHARE)
22. 6.22 SECURITY, ACCESS CONTROL AND ROBOTICS, BY SOURCE, 2024 TO 2035 (USD Billion)
23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY FORM, 2025-2035 (USD Billion)
  2. 7.2.2 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  3. 7.2.3 BY CATEGORY, 2025-2035 (USD Billion)
  4. 7.2.4 BY TYPE OF MEDICINAL PLANTS, 2025-2035 (USD Billion)
  5. 7.2.5 BY SOURCE, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China Security, Access Control and Robotics Market Segmentation

Security, Access Control and Robotics By Form (USD Billion, 2025-2035)

Extracts
Powders
Capsules & Tablets
Syrups

Security, Access Control and Robotics By Distribution Channel (USD Billion, 2025-2035)

Hospital & Retail Pharmacies
E-Commerce

Security, Access Control and Robotics By Category (USD Billion, 2025-2035)

Herbal Pharmaceuticals
Herbal Functional Foods
Herbal Beauty Products
Herbal Dietary Supplements

Security, Access Control and Robotics By Type of Medicinal Plants (USD Billion, 2025-2035)

Marrubium Vulgare
Vaccinium Macrocarpon
Echinacea
Curcuma Longa
Camellia Sinensis
Actaea Racemose
Aloe Vera
Zingiber Officinale
Cocos Nucifera
Cinnamomum Spp
Allium Sativum

Security, Access Control and Robotics By Source (USD Billion, 2025-2035)

Leaves
Root & Barks
Whole Plants
Fruits

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”